According to a study published in The New England Journal of Medicine, the ability to customize open-source, “do-it-yourself” automated insulin delivery (AID) systems may make them more effective at controlling blood glucose than conventional sensor-augmented insulin pumps.
A 97-subject clinical trial by researchers in New Zealand has found that people with Type 1 diabetes who used the AID system (an open-source artificial pancreas that runs on Android devices, a DANA-i insulin pump and a Dexcom G6 continuous glucose monitor) spent 3 hours and 21 minutes more in the target range per day than their counterparts in the control group.
“Open-source AIDs may be more customizable and more widely available than commercial systems, though these potential benefits should be balanced against possible difficulties configuring open-source systems, lack of regulatory approval, and limited trial data,” a physician not connected to the study wrote in an accompanying editorial.
To read more, CLICK HERE.